Stefania Stefani

Academic and scientific qualification: ➢ President of the School of Medicine, UNICT November 2022- May 2023 ➢ Member of working group for optimal antibiotic prescription - AIFA – since September 2021 ➢ Coordinator of the PhD College “Basic and Applied Biomedical Sciences” since October 2019 ➢ Member of the Technical and Scientific Committee for Coronavirus OCDPC n.630/2020 ➢ President of the Italian Society of Microbiology (SIM) since September 2019 ➢ Member of the National Board of evaluation of Italian professorship (ASN) 2019-2021 ➢ Member of Sicilian board for PNCAR application – Assessorato Regionale alla Sanità, ➢ DA 870, since May 17, 2018 ➢ Member of the Board of Microbiome and Probiotics- Italian Minister of Health (2018) ➢ Member of the PhD College “Basic and Applied Biomedical Sciences” (since 2017) ➢ Consultant at the Policlinico University Hospital for advanced bacteriology (since 2017) ➢ Member of the Board PNCAR (nominee DD November 3, 2017) Italian Minister of Health ➢ Member of the board IDSA-ESCMID for S.aureus bacteremia BSA guidelines (2017) ➢ Member of the Board of the Italian Minister of Health for the Antimicrobial Resistance Plan (2016-2017) ➢ President of the Research and Innovation Technology Lab (BRIT) (since 2016) ➢ Member of College PhD in “Translational Bio-medicine” (2014-2016) ➢ Board of Trustees of the International Society of Chemotherapy (ISC) – (2013) ➢ Rector's Delegate for the Scientific Research of the University of Catania (2013-2016). ➢ Editor in Chief of Journal of Global Antimicrobial Resistance JGAR (Elsevier) since 2012 ➢ Editorial Scientific Board: Section Editor of International Journal Antimicrob Agents since 2006, Annals of Microbiology since 2009, Libyan Journal of Medicine since 2010, Microbiology since 2013 ➢ Member of the National Board of evaluation of Italian professorship (ASN) 2013-2014 ➢ Reviewer: Journal Chemotherapy, Annals of Microbiology, Medical Science Monitor, Infezioni in Medicina, Research in Microbiology, J. Infectious Diseases, J. Hospital Infections, Expert Opinion in Pharmacology, Key Opinions, Clinical Microbiology and Infection, Journal Antimicrobial Chemotherapy, Microbiology, Future in microbiology, Frontiers in Microbiology. ➢ Member of the sub Committee for antimicrobial resistance EUCAST subcommittee of the ESCMID; ➢ Member of the Scientific Board of: Società Italiana di Microbiologia (SIM); Società .Italiana Microbiologia Generale Biotecnologie Microbiche (SIMGBM); Società italiana di microbiologia 2 medica, odontoiatrica e clinica (SIMMOC); Italian Society of Clinical Microbiology (AMCLI); Società Italiana di Chemioterapia (SIC); American Society for Microbiology (ASM), International Society of Chemotherapy (ISC). ➢ Scientific Advisory Committee (SAC) dell’ European Society of Clinical Microbiology and Infectious diseases (ESCMID) (until 2012) ➢ General Secretary of Società Mediterranea di Chemioterapia (MSC) ➢ Tresaure of ’Accademia Gioenia. (until 2012) ➢ Patent N. RM2010A000163 – SIB B 4106R – Use of S.salivarius in the treatment of respiratory infections ➢ Consultant at the University Hospital, under contract with the Cannizzaro hospital for Advanced molecular diagnostics (2012-2016) Projects: Good experience as principal investigator of Projects funded by National or International Grant Agencies (PRIN, VI and VII FP –EU). Experience as project evaluator (V, VI FP and VII of the EU) and for the Vinci and Galileo projects (Italy-France cooperation projects); Evaluator of the JPIAMR program (2019); Evaluator of Research project of Minister of research, Bonn (2019) and Dublin (2019-2020) ; Evaluator of Projects AIFA (2019) Experience as project evaluator for the Italian Ministero della Salute. Experience as project evaluator for the Universities of Milan and Naples. Activity of supervisions of PhD students, Postdoctoral fellows and Research students since 1990. Awards – ESCMID fellow and ISAC fellow